推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 曹洪欣指出，首先說文化壁壘。中藥是治病救人的，中醫(yī)藥則是中華優(yōu)秀文化和人體生命現(xiàn)象的結(jié)合，所以中藥治病和西藥不完全一樣。比如中醫(yī)藥多成分、多靶點(diǎn)的治療方式，其作用部位比較廣泛，和西藥單靶點(diǎn)對抗治療完全不一樣。
第二個是技術(shù)壁壘。技術(shù)就是指中藥炮制等技術(shù)，這些是中國獨(dú)有的技術(shù)，因此，炮制技術(shù)該如何適應(yīng)現(xiàn)代技術(shù)就成為了一個難點(diǎn)。另外如何有效引入最先進(jìn)的技術(shù)提高制藥水平和能力等也是難點(diǎn)。
第三個是醫(yī)療服務(wù)中傳承文化壁壘。中醫(yī)藥走向世界一方面能夠治人治病，另外一方面則是可以把中華優(yōu)秀文化帶出去。但是中華文化與世界文化在交融過程中該怎樣占領(lǐng)主導(dǎo)權(quán)？這就涉及到了制定標(biāo)準(zhǔn)問題。
曹洪欣表示，“十一五”、“十二五”中，在行業(yè)專項(xiàng)和重大項(xiàng)目創(chuàng)建中研制了互相認(rèn)可標(biāo)準(zhǔn)。中藥進(jìn)入當(dāng)?shù)乇仨氁m應(yīng)當(dāng)?shù)氐臉?biāo)準(zhǔn)，比如適應(yīng)歐美的標(biāo)準(zhǔn)、適應(yīng)澳大利亞的標(biāo)準(zhǔn)等。
